cancer targeted therapy market

Global Cancer Targeted Therapy Market Research by Company, Type & Application 2015-2026

  • Published Date: 2021-01-28
  • Report ID: 48464
  • Pages: 132
  • Format: prudent report format

Summary

Prudent Markets estimates that the Cancer Targeted Therapy market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025.
In this report, Prudent Markets discusses the Global & China industrial policies, economic environment, and the impact of covid-19 on the Cancer Targeted Therapyindustry and its cost structure. Besides, this report covers the basic market dynamics, market size and companies competition data. In addition, the report also conducts basic market research on major product type, market end-use and regional trade.
Market Segment as follows:
Product Type Segmentation Includes
Tumor Antigens As Targets of Antibodies
Development of Antibodies for Clinical Purposes
Complement Dependent Cytotoxicity (CDC)
Signal Transduction Changes
Application Segmentation Includes
Hospital
Clinic
Others
Companies Includes
Advaxis
Bind Therapeutics
Boehringer Ingelheim
Bristol Mayer Squibb
Celldex Therapeutics
Dendreon Corporation
Eli Lily
GalaxoSmithKline
Galena Biopharma
Genetech
ImmunoCellular Therapeutics
ImmunoGen
Inovio Pharmaceuticals
Johnson & Johnson
NeoStem Oncology
NewLink Genetics
Northwest Biotherapeutics
Merck
Novartis
Peregrine Pharmaceuticals
Pfizer
Roche
Sanofi
Seattle Genetics
Teva
The main contents of the report including:
Section 1:
Product definition, type and application, Global & China market overview;
Section 2:
Global & China Market competition by company;
Section 3:
Global & China sales revenue, volume and price by type;
Section 4:
Global & China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
Industrial policies & economic environment
Section 9:
Conclusion.
For any other requirements, please feel free to contact Prudent Markets for customized contents.


Table of Contents
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Tumor Antigens As Targets of Antibodies
1.1.2.2 Development of Antibodies for Clinical Purposes
1.1.2.3 Complement Dependent Cytotoxicity (CDC)
1.1.2.4 Signal Transduction Changes
1.1.3 Market by Application
1.1.3.1 Hospital
1.1.3.2 Clinic
1.1.3.3 Others
1.2 Global & China Market Size & Forecast
1.2.1 Global Market (2015-2020 & 2021-2026)
1.2.2 China Market (2015-2020 & 2021-2026)
2 Global & China Market by Company
2.1 Global Sales by Company
2.2 China Sales by Company
3 Global & China Market by Type
3.1 Global Sales by Product Type
3.2 China Sales by Product Type
4 Global & China Market by Application
4.1 Global Sales by Application
4.2 China Sales by Application
5 China Trade
5.1 Export Overview
5.2 Import Overview
6 Key Companies List
6.1 Advaxis
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Bind Therapeutics
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Boehringer Ingelheim
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Bristol Mayer Squibb
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Celldex Therapeutics
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Dendreon Corporation
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Eli Lily
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 GalaxoSmithKline
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Galena Biopharma
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Genetech
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 ImmunoCellular Therapeutics
6.11.1 Company Information
6.11.2 Product Specifications
6.11.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.12 ImmunoGen
6.12.1 Company Information
6.12.2 Product Specifications
6.12.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.13 Inovio Pharmaceuticals
6.13.1 Company Information
6.13.2 Product Specifications
6.13.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.14 Johnson & Johnson
6.14.1 Company Information
6.14.2 Product Specifications
6.14.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.15 NeoStem Oncology
6.15.1 Company Information
6.15.2 Product Specifications
6.15.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.16 NewLink Genetics
6.16.1 Company Information
6.16.2 Product Specifications
6.16.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.17 Northwest Biotherapeutics
6.17.1 Company Information
6.17.2 Product Specifications
6.17.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.18 Merck
6.18.1 Company Information
6.18.2 Product Specifications
6.18.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.19 Novartis
6.19.1 Company Information
6.19.2 Product Specifications
6.19.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.20 Peregrine Pharmaceuticals
6.20.1 Company Information
6.20.2 Product Specifications
6.20.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.21 Pfizer
6.21.1 Company Information
6.21.2 Product Specifications
6.21.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.22 Roche
6.22.1 Company Information
6.22.2 Product Specifications
6.22.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.23 Sanofi
6.23.1 Company Information
6.23.2 Product Specifications
6.23.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.24 Seattle Genetics
6.24.1 Company Information
6.24.2 Product Specifications
6.24.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.25 Teva
6.25.1 Company Information
6.25.2 Product Specifications
6.25.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
7 Industry Upstream
7.1 Industry Chain
7.2 Upstream Overview
8 Policies & Market Environment
8.1 Policies
8.1.1 Major Regions Policies
8.1.2 Policies in China
8.2 Market Environment
8.2.1 Porter's Five Forces
8.2.2 Impact of COVID-19
9 Research Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.